113 related articles for article (PubMed ID: 35870426)
21. The role of P62 in the development of human thyroid cancer and its possible mechanism.
Mao Y; Deng SJ; Su YJ; Diao C; Peng Y; Ma JF; Cheng RC
Cancer Genet; 2021 Aug; 256-257():5-16. PubMed ID: 33780725
[TBL] [Abstract][Full Text] [Related]
22. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.
Yin JJ; Cheng XY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097
[TBL] [Abstract][Full Text] [Related]
24. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
[TBL] [Abstract][Full Text] [Related]
25. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
26. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
27. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
28. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
[TBL] [Abstract][Full Text] [Related]
29. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
31. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
32. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
[TBL] [Abstract][Full Text] [Related]
33. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
[TBL] [Abstract][Full Text] [Related]
34. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
[TBL] [Abstract][Full Text] [Related]
35. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
[TBL] [Abstract][Full Text] [Related]
36. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
[TBL] [Abstract][Full Text] [Related]
37. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
Qin A; Liu Q; Wang J
Drug Dev Res; 2020 Sep; 81(6):700-707. PubMed ID: 32314406
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
Ma J; Kan Z
Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]